Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
6.39
+0.39 (6.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $943.03 million as of December 20, 2024. Its market cap has increased by 39.78% in one year.
Market Cap
943.03M
Enterprise Value
900.36M
1-Year Change
39.78%
Ranking
Category
Stock Price
$6.39
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $943.03M, a decrease of -80.25%. That is a compound annual growth rate of -25.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 943.03M | 32.94% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | 8.09B | 117.39% |
| Dec 31, 2019 | 3.72B | -22.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 904.84M |
| Pacira BioSciences | 903.61M |
| Liquidia | 896.30M |
| Phibro Animal Health | 883.38M |
| AMN Healthcare Services | 873.79M |
| Aveanna Healthcare Holdings | 873.38M |
| ArriVent BioPharma | 864.33M |
| Cogent Biosciences | 861.60M |